News
-
New campaign: Be critical when using health apps
| 22 March 2017 |
The Danish Medicines Agency has launched a new campaign on its website and Facebook to encourage consumers to be critical when they use health apps they have downloaded or bought on the internet.
-
New recommendation for phasing out zinc oxide for young pigs
| 21 March 2017 |
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has confirmed a previous decision to phase out zinc oxide. Consequently, the CVMP has once more recommended to the European Commission that medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs should be withdrawn from the market.
-
Withdrawal of a batch of EpiPen® 300 micrograms
| 17 March 2017 |
MEDA recalls a batch of the adrenaline product EpiPen® 300 micrograms/dose, which is used for sudden allergic reactions. There is a risk that the auto-injector does not work. The withdrawal concerns product number 578818 with batch number: 5FA665B and expiry date 03/2017.
-
Chinese delegation is visiting the Danish Medicines Agency today
| 13 March 2017 |
The Danish Medicines Agency and the Chinese Food and Drug Administration, CFDA, take another big step towards closer cooperation.
-
EuropharmaDK regains its authorisation
| 13 March 2017 |
The Danish Medicines Agency has decided to lift the suspension of EuropharmaDK's manufacturing and importation authorisation, following the outcome of a follow-up inspection of EuropharmaDK ApS on 8 March where the Danish Medicines Agency ascertained that the critical findings had been corrected.
-
Danish Pharmacovigilance Update, February 2017
| 06 March 2017 |
The February issue of Danish Pharmacovigilance Update.
-
New transatlantic agreement on mutual recognition of inspections
| 03 March 2017 |
The EU and the USA have agreed to recognise inspections of manufacturing sites for human medicines conducted in their respective territories on both sides of the Atlantic.